Assoc. Prof. Dr. Hany Fayed | Pharmacology | Best Researcher Award

Posted on by Academic achievements

Assoc. Prof. Dr. Hany Fayed | Pharmacology | Best Researcher Award

Assoc. Prof. Dr. Hany Fayed | Pharmacology – Associate professor at National Research Centre, Egypt

Dr. Hany Moawad Ali Fayed is an Associate Professor of Pharmacology and Toxicology at the Medical Research and Clinical Studies Institute, National Research Centre (NRC), Egypt. With a remarkable academic background and over a decade of research experience, Dr. Fayed is widely recognized for his groundbreaking work in the fields of pharmacology and toxicology, especially in the study of liver diseases and hepatotoxicity. His research has contributed extensively to understanding the therapeutic potential of various compounds in treating liver fibrosis and related disorders, leading to significant advancements in both academic and clinical settings. Throughout his career, he has demonstrated a keen ability to integrate teaching with research, mentoring students while simultaneously pushing forward innovative scientific research. His publications and contributions to major international journals showcase his dedication to advancing pharmacological and toxicological knowledge.

Profile Verified:

Orcid | Google Scholar

Education:

Dr. Fayed’s academic journey began with a Bachelor of Veterinary Medical Sciences from Menofiya University, Egypt, where he graduated with distinction in 2007. He then pursued a Master’s degree in Veterinary Pharmacology at Cairo University, where he developed a keen interest in hepatoprotection and toxicology, culminating in his thesis on the hepatoprotective effects of artichoke extract against hepatocellular carcinoma in rats. His pursuit of excellence led him to a Ph.D. in Veterinary Pharmacology from Cairo University in 2017, where his dissertation focused on the evaluation of osteopontin in liver fibrosis, a study that significantly advanced the understanding of liver fibrosis mechanisms. Dr. Fayed’s robust educational background laid a solid foundation for his continued work in pharmacology and toxicology, making him a recognized expert in the field.

Experience:

Dr. Fayed’s professional experience spans over a decade, during which he has held pivotal positions in academia and research. From 2012 to 2022, he contributed as an educator at Cairo University, teaching pharmacological and toxicological experiments to veterinary students. This role allowed him to merge his passion for research with his dedication to training future scientists. Since 2015, Dr. Fayed has served as a researcher at the Medical Research and Clinical Studies Institute at NRC, progressing to an Associate Professor in 2023. Throughout his tenure at NRC, he has led various high-impact research projects and contributed to advancing pharmacological therapies, particularly in liver diseases and fibrosis. His involvement in both independent and collaborative research efforts has led to significant findings, reinforcing his position as a leader in his field.

Research Interest:

Dr. Fayed’s primary research interests are centered around pharmacology, toxicology, and liver diseases, with a focus on liver fibrosis, hepatotoxicity, and the molecular mechanisms of pharmacological agents. His recent research includes exploring the therapeutic effects of Canagliflozin and Linagliptin in liver carcinogenesis and the role of natural products in mitigating liver damage. He is also deeply involved in investigating the signaling pathways involved in liver fibrosis, such as AMPK/YAP/TAZ, IL-6/STAT3, and NRF2/HO-1, and their potential as therapeutic targets. His work on natural products, like Sansevieria species, also underscores his commitment to exploring alternative therapies for liver protection. Dr. Fayed’s interdisciplinary research is shaping the future of pharmacology and toxicology, providing essential insights into the treatment of liver diseases.

Award:

Dr. Fayed’s academic and professional excellence has not gone unnoticed. He was honored with the prestigious National Research Centre Prize for the Best Ph.D. Thesis in the Medical Division in 2017-2018. This recognition is a testament to his exceptional research contributions to the field of pharmacology and toxicology, particularly in the study of liver fibrosis. Additionally, Dr. Fayed’s continued success in securing research grants and leading innovative projects reflects his sustained contribution to scientific advancement. His recognition by both national and international bodies highlights his reputation as a highly respected researcher in the field.

Publications:

Dr. Fayed has an extensive publication record in reputable scientific journals. Notable publications include:

  1. “Hepatoprotective Effect of Artichoke Extract Against Pre-cancerous Lesions of Hepatocellular Carcinoma in Rats” (2014), Life Science Journal.
    This study explored the protective effects of artichoke extract against liver cancer, contributing to the growing body of research on natural hepatoprotective agents. 📚
  2. “Molecular Mechanisms Underlying Hepatoprotective Effects of Artichoke Extract” (2014), World Journal of Pharmacy and Pharmaceutical Sciences.
    This paper delves into the biochemical pathways through which artichoke extract modulates liver damage, establishing it as a key area for further research. 🌱
  3. “Mesalazine: The Potential Prophylactic and Remedial Roles in Induced Liver Fibrosis in Rats” (2018), Chemico-Biological Interactions.
    This publication highlighted the therapeutic potential of Mesalazine in treating liver fibrosis, demonstrating its role in combating liver damage. 🧪
  4. “Targeting AngII/AT1R Signaling Pathway by Perindopril Inhibits Ongoing Liver Fibrosis in Rat” (2019), Journal of Tissue Engineering and Regenerative Medicine.
    This research provided insights into the pharmacological mechanisms of Perindopril in mitigating liver fibrosis, showing its clinical potential. 💊
  5. “Metabolomic Profiling of Sansevieria trifasciata and Hepatoprotective Effect in Liver Fibrosis” (2021), Egyptian Journal of Chemistry.
    This study explored the hepatoprotective effects of Sansevieria species and their biochemical properties, offering new avenues for natural liver therapies. 🌿
  6. “Rosuvastatin Restrains Liver Fibrosis: Involvement of NF-κB and Nrf2/HO-1 Pathways” (2022), International Journal of Veterinary Science.
    This publication investigated the therapeutic potential of Rosuvastatin in treating liver fibrosis, contributing to the understanding of its molecular mechanisms. 🧬
  7. “Erythropoietin Suppresses Hepatic Fibrosis Caused by Thioacetamide: Role of PI3K/Akt and TLR4 Signaling Pathways” (2023), Oxidative Medicine and Cellular Longevity.
    This paper presented novel insights into the use of Erythropoietin for treating hepatic fibrosis, particularly in relation to key cellular signaling pathways. 🔬

Conclusion:

Dr. Hany Moawad Ali Fayed’s contributions to pharmacology and toxicology, particularly in liver disease research, demonstrate his unwavering commitment to advancing science. His work has provided critical insights into the molecular mechanisms behind liver fibrosis and hepatotoxicity, making him a leading figure in the field. Through his numerous publications, award-winning research, and dedication to teaching and mentoring, Dr. Fayed continues to shape the future of pharmacological sciences. His achievements are a testament to his expertise and passion for research, positioning him as an outstanding candidate for the “Best Researcher Award.”

 

 

 

 

Dr. Priyanka Banerjee | Pharmacology | Women Researcher Award

Posted on by Academic achievements

Dr. Priyanka Banerjee | Pharmacology | Women Researcher Award

Dr. Priyanka Banerjee | Pharmacology – Charité Universitätsmedizin Berlin, Germany

Dr. Priyanka Banerjee is a distinguished researcher in the field of computational toxicology and cheminformatics, currently serving as a Principal Investigator at Charité – University of Medicine, Berlin. Her work bridges artificial intelligence, pharmacology, and biomedical data science, focusing on predicting toxicity, adverse drug reactions, and improving treatment outcomes using machine learning. She has successfully led funded research projects, mentored young scientists, and published widely cited research, establishing herself as a leader in AI-driven healthcare solutions. Her research has practical implications in both academic and industrial settings, including drug discovery, taste prediction, and allergen identification.

Profile Verified:

Orcid | Scopus | Google Scholar

🎓 Education:

Dr. Banerjee holds a PhD in Medical Sciences from Humboldt University of Berlin, where her research centered on cheminformatics-based prediction of off-target drug effects. She completed her Master’s degree at the University of Bonn, specializing in algorithmic approaches to peptidomimetics, and earned her undergraduate degree in biochemistry from Bangalore University. She is currently finalizing her Habilitation at Charité – University of Medicine, expected in 2025. Her academic trajectory reflects consistent excellence and a multidisciplinary approach that combines chemistry, biology, and data science.

🧑‍🔬 Experience:

With over eight years of postdoctoral research experience, Dr. Banerjee has held key roles as a Lecturer, Postdoctoral Fellow, and now as a Research Group Leader. Since 2020, she has led multiple interdisciplinary projects, including AI-based chemical taste prediction (SimLeapTasteAI), food allergen modeling, and real-world data analysis for improved clinical decision-making. Previously, during her postdoc years, she co-developed the widely-used ProTox platform and contributed to method development for natural product synthesis and toxicity analysis. Her leadership is reflected in successful grant acquisition, cross-sectoral collaboration, and a strong mentorship record.

🔬 Research Interest:

Dr. Banerjee’s research is rooted in patient-centric drug discovery and toxicity assessment. She focuses on integrating theoretical modeling with experimental data to understand molecular mechanisms and predict safety profiles of drugs and chemicals. Key areas include computational toxicology, structural bioinformatics, real-world evidence analysis, and adverse drug event prediction. Her interests also extend to chemical taste modeling, allergen profiling, and ethical AI applications in medical sciences, aiming to reduce animal testing and improve drug safety through data-driven innovation.

🏆 Awards:

Dr. Banerjee’s contributions have been widely recognized. She was shortlisted for the Lush Prize (2016) for her PhD work on non-animal testing alternatives, one of the most prestigious global awards in toxicology and animal welfare. She received a PhD Fellowship from the German Research Foundation (DFG) and was awarded a Visiting Research Grant to collaborate with the La Jolla Institute for Allergy and Immunology in the USA. These accolades highlight her international impact and dedication to ethical, high-quality research.

📚 Selected Publications:

  • 🧪 “The investigation of the toxicity of organophosphorus flame retardants (OPFRs)” – Toxicology Mechanisms and Methods, 2025. Cited by 3 articles.
  • 🧬 “Targeting mutation sites in the Omicron variant of SARS-CoV-2 using antiretroviral drugs” – Toxicology Reports, 2024. Cited by 0 articles.
  • 🧠 “Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring” – Nature Communications, 2024. Cited by 2 articles.
  • 💊 “ProTox-II: A webserver for the prediction of toxicity of chemicals” – Nucleic Acids Research, 2018. Cited by 1,200+ articles.
  • 🧫 “VirtualTaste: A machine learning platform for chemical taste prediction” – Journal of Cheminformatics, 2022. Cited by 120 articles.
  • 🌐 “AI-driven identification of food allergens from molecular profiles” – Frontiers in Allergy, 2021. Cited by 65 articles.
  • 🧮 “Structure-based prediction of adverse drug reactions using RWE” – Briefings in Bioinformatics, 2023. Cited by 40 articles.

✅ Conclusion:

Dr. Priyanka Banerjee is a visionary mid-career scientist whose interdisciplinary research addresses critical challenges at the intersection of AI, toxicology, and drug safety. Her scientific excellence is matched by her dedication to collaboration, mentorship, and ethical research practices. With strong international recognition, high-impact publications, and funded leadership roles, she stands out as a role model in biomedical data science. Dr. Banerjee embodies the principles and promise of the Women Researcher Award, and her continued contributions are poised to shape the future of personalized and safe medicine.

 

 

 

Stuart Maudsley | Pharmacology | Best Researcher Award

Posted on by Academic achievements

Prof. Dr. Stuart Maudsley | Pharmacology | Best Researcher Award

Prof. Dr. Stuart Maudsley | Pharmacology – Professor at Moffitt Cancer Center, United States

Dr. Stuart Russell Maudsley is an esteemed researcher and principal investigator whose work has had a profound impact on the field of pharmacology, particularly in the study of G-protein-coupled receptors (GPCRs). His career has been marked by significant contributions to cancer research, aging, and molecular gerontology, leading to the development of innovative therapeutic strategies aimed at treating complex human diseases. Dr. Maudsley’s work focuses on the precision targeting of GPCRs to develop treatments for a wide range of conditions, from cancer to neurodegenerative disorders, with a unique approach that blends basic science with clinical applications. He has been instrumental in leading transformative research at Moffitt Cancer Center and has earned widespread recognition for his contributions in both academia and industry.

Profile:

Scopus

Education:


Dr. Maudsley earned his Ph.D. in Pharmacology from the University of Leeds, UK, after completing a First-Class Bachelor’s degree in Pharmacology at the same institution. His doctoral research focused on electrophysiological and molecular biological studies of Tachykinin receptors, which set the stage for his continued exploration of receptor biology. His academic journey laid the groundwork for a career dedicated to uncovering the complex molecular mechanisms that regulate cellular behavior and how these processes can be manipulated for therapeutic purposes. His early education and research provided a foundation for his later innovations in the field of pharmacology and receptor therapeutics.

Experience:


Dr. Maudsley’s career spans several prestigious roles that highlight his leadership and expertise in pharmacology and receptor biology. He currently serves as the principal investigator at Moffitt Cancer Center, where he directs the Maudsley Lab, focusing on receptor biology and cancer therapeutics. His work is particularly notable for its precision in targeting GPCRs to treat cancer and other complex diseases. Dr. Maudsley also co-founded HeptOME – Receptor Therapeutics, and his position as a Special Science Advisor for the Belgian Superior Health Council reflects his international influence. His experience in both academic and industry settings has allowed him to bridge the gap between cutting-edge research and real-world therapeutic solutions.

Research Interests:


Dr. Maudsley’s primary research interest lies in the molecular and pharmacological study of GPCRs, a class of receptors that play a crucial role in various cellular processes. He focuses on understanding how these receptors regulate human diseases, particularly cancer, aging, and neurodegenerative disorders. By investigating the intricate mechanisms of GPCR signaling, Dr. Maudsley aims to develop novel targeted therapies that can improve treatment outcomes in these complex diseases. His research extends to systems pharmacology, which integrates multidimensional approaches to identify new drug targets and improve therapeutic strategies. Dr. Maudsley is particularly interested in the therapeutic application of GPCR-targeted medicines and their potential to treat diseases with unmet medical needs.

Awards:


Dr. Maudsley has received numerous accolades for his pioneering research in pharmacology and receptor biology. His work has been consistently recognized for its potential to revolutionize therapeutic strategies for cancer and aging-related diseases. He has been invited to speak at prestigious international conferences and has received several awards from scientific and medical societies for his contributions to understanding receptor biology. His recognition as a co-founder of HeptOME – Receptor Therapeutics further highlights his entrepreneurial spirit and ability to translate scientific discoveries into practical applications that benefit patients worldwide.

Publications:


Dr. Maudsley has an extensive publication record, contributing to major scientific journals and collaborative research projects. A few notable publications include:

  1. Maudsley S., Leysen H., van Gastel J., Martin B. (2021). Systems Pharmacology: Enabling Multidimensional Therapeutics, Reference Module in Biomedical Sciences. 📖
  2. Maudsley S., Schrauwen C., Harputluoğlu İ., Walter D., Leysen H., McDonald P. (2023). GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process, Int J Mol Sci. 🔬
  3. Schreurs G., Maudsley S., Nast C., Praet M., Da Silva Fernandes S., Boor P., D’Haese P., De Broe M.E., Vervaet B.A. (2023). Chronic Dehydration Induces Injury Pathways in Rats, Sci Rep. 🧪
  4. Maudsley S., Leysen H., Walter D., Vandoren R. (2023). GPCRs Regulate DNA Integrity, Encyclopedia – Biochemistry and Molecular Biology. 📑
  5. Coppens V., De Wachter O., Goossens J., Hendrix J., Maudsley S., Azmi A., van Gastel J., Van Saet A., Lauwers T., Morrens M. (2020). Profiling of Peripheral Blood Mononuclear Cells for Schizophrenia Biomarkers, Neuropsychobiology. 🧠
  6. Van Meenen J., Leysen H., Chen H., Baccarne R., Walter D., Martin B., Maudsley S. (2022). Making Biomedical Sciences Publications More Accessible for Machines, Med Health Care Philos. 💻
  7. Leysen H., Maudsley S., Van Gastel J., Martin B. (2021). The RXFP3 Receptor is a Modulator of Aging-Related Disease, Int J Mol Sci. 🧬

Conclusion:


Dr. Stuart Russell Maudsley’s extensive contributions to pharmacology, especially in the area of GPCRs and their role in complex diseases, make him an exceptional candidate for the Best Researcher Award. His research, which bridges the gap between basic science and clinical applications, continues to shape the future of precision medicine. Through his innovative work at Moffitt Cancer Center and his involvement in entrepreneurial ventures like HeptOME – Receptor Therapeutics, Dr. Maudsley has made a lasting impact on both academia and industry. His leadership in the field and his commitment to advancing therapeutic solutions for cancer, aging, and neurodegenerative diseases position him as a truly deserving nominee for this prestigious award.

Dr. Faridah Bt Kormin – Pharmacology – Trailblazing Academic Award

Posted on by Academic achievements

Dr. Faridah Bt Kormin - Pharmacology - Trailblazing Academic Award

UTHM - Malaysia

Professional Profiles

Early Academic Pursuits

Dr. Faridah Bt Kormin embarked on her academic journey with a fervent passion for knowledge. She pursued her education diligently, laying a strong foundation for her future endeavors. Her commitment to academic excellence paved the way for her to become an Associate Professor and lecturer at Universiti Tun Hussein Onn Malaysia (UTHM), where she has made significant contributions to the field of applied sciences and technology.

Professional Endeavors

With an illustrious career spanning over eight years, Dr. Faridah has honed her expertise through diverse professional experiences. She has served as an executive and researcher at esteemed institutions such as the University of Malaya, the Malaysian Agriculture Research and Development Institute (MARDI), and within the food and pharmaceutical industries. Her multifaceted background has equipped her with valuable insights and skills that she brings to her current role as Deputy Director of the Department (Community Network and Knowledge Transfer) at the Industry and Community Relation Centre, UTHM. In this capacity, she focuses on knowledge transfer, community service, and enhancing the university's community engagement program.

Contributions and Research Focus On Pharmacology

Dr. Faridah's research endeavors are characterized by their breadth and depth, covering a diverse range of topics within the field of applied sciences. Her expertise spans food safety and quality, food processing technology, microwave extraction, membrane separation technology, and polymer science. Currently, her research interests include nanotechnology-based medicine delivery, the development of cosmeceutical products containing rhinoceros chitin, the production of biodegradable plastic derived from black soldier fly exuviae, and improving iron bioavailability in healthy cookies. Through her research, Dr. Faridah aims to address pressing challenges and contribute to the advancement of knowledge in her field.

Accolades and Recognition In Pharmacology

Dr. Faridah's contributions to academia and research have been recognized through numerous accolades and certifications. She has supervised and mentored several master's and Ph.D. students, guiding them to successful graduation. Additionally, she has managed numerous research funds from national, industry, and international sources, demonstrating her ability to secure and execute research projects effectively. Her active involvement in prestigious organizations such as the Malaysian Institute of Food Technologists (MIFT) and the Malaysian Board of Technologists (MBOT) further attests to her standing in the academic community.

Impact and Influence

Dr. Faridah's impact extends beyond academia, as she actively engages with industry and provides valuable consulting services to businesses, particularly micro, small, and medium-sized enterprises. Her expertise in areas such as Halal certification, Good Manufacturing Practices (GMP), Hazard Analysis and Critical Control Points (HACCP), and food labeling has helped businesses navigate regulatory requirements and ensure compliance with industry standards. Through her consultancy work, Dr. Faridah contributes to the growth and sustainability of businesses while promoting food safety and quality practices.

Legacy and Future Contributions For

Dr. Faridah's multifaceted contributions to academia, research, and community engagement exemplify her dedication to advancing knowledge and fostering practical solutions in her field. As she continues her academic journey, she remains committed to making meaningful contributions to applied sciences and technology, addressing societal challenges, and nurturing the next generation of researchers and industry professionals. Her legacy is marked by her passion for learning, her commitment to excellence, and her unwavering dedication to making a positive impact in her community and beyond.

Notable Publications

Comparison of phytochemicals, antioxidant and anti-cholinesterase activity of unripe and ripe fruit of sonneratia caseolaris 2020

Development and evaluation of polyherbal formulation for memory enhancement: Study on its antioxidant properties and synergistic effects 2020

Effects of various drying methods on selected physical and antioxidant properties of extracts from moringa oliefera leaf waste 2020

In vitro phytochemicals, antioxidant and anti-acetylcholinesterase activities of ficus deltoidea infusion 2020